| Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2–mediated drug resistance Z Shi, XX Peng, IW Kim, S Shukla, QS Si, RW Robey, SE Bates, T Shen, ... Cancer research 67 (22), 11012-11020, 2007 | 340 | 2007 |
| Sildenafil reverses ABCB1-and ABCG2-mediated chemotherapeutic drug resistance Z Shi, AK Tiwari, S Shukla, RW Robey, S Singh, IW Kim, SE Bates, ... Cancer research 71 (8), 3029-3041, 2011 | 183 | 2011 |
| Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo Z Shi, Y Liang, Z Chen, X Wang, X Wang, Y Ding, L Chen, X Yang, L Fu Cancer biology & therapy 5 (1), 39-47, 2006 | 172 | 2006 |
| Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production Z Shi, WM Yang, LP Chen, DH Yang, Q Zhou, J Zhu, JJ Chen, RC Huang, ... Breast cancer research and treatment 135, 737-747, 2012 | 132 | 2012 |
| Cyclooxygenase-2 in glioblastoma multiforme J Qiu, Z Shi, J Jiang Drug discovery today 22 (1), 148-156, 2017 | 127 | 2017 |
| Resveratrol oligomers for the prevention and treatment of cancers YQ Xue, JM Di, Y Luo, KJ Cheng, X Wei, Z Shi Oxidative Medicine and Cellular Longevity 2014 (1), 765832, 2014 | 120 | 2014 |
| Therapeutic potential of steroidal alkaloids in cancer and other diseases QW Jiang, MW Chen, KJ Cheng, PZ Yu, X Wei, Z Shi Medicinal research reviews 36 (1), 119-143, 2016 | 116 | 2016 |
| Erastin reverses ABCB1-mediated docetaxel resistance in ovarian cancer HH Zhou, X Chen, LY Cai, XW Nan, JH Chen, XX Chen, Y Yang, ZH Xing, ... Frontiers in oncology 9, 1398, 2019 | 98 | 2019 |
| Recent insights into the biological activities and drug delivery systems of tanshinones Y Cai, W Zhang, Z Chen, Z Shi, C He, M Chen International Journal of Nanomedicine, 121-130, 2016 | 96 | 2016 |
| Piperlongumine induces apoptosis and synergizes with cisplatin or paclitaxel in human ovarian cancer cells LH Gong, XX Chen, H Wang, QW Jiang, SS Pan, JG Qiu, XL Mei, YQ Xue, ... Oxidative medicine and cellular longevity 2014 (1), 906804, 2014 | 94 | 2014 |
| Triterpenoids as reversal agents for anticancer drug resistance treatment XJ Yan, LH Gong, FY Zheng, KJ Cheng, ZS Chen, Z Shi Drug Discovery Today 19 (4), 482-488, 2014 | 89 | 2014 |
| Sildenafil inhibits the growth of human colorectal cancer in vitro and in vivo XL Mei, Y Yang, YJ Zhang, Y Li, JM Zhao, JG Qiu, WJ Zhang, QW Jiang, ... American journal of cancer research 5 (11), 3311, 2015 | 84 | 2015 |
| Inhibiting the function of ABCB1 and ABCG2 by the EGFR tyrosine kinase inhibitor AG1478 Z Shi, AK Tiwari, S Shukla, RW Robey, IW Kim, S Parmar, SE Bates, QS Si, ... Biochemical pharmacology 77 (5), 781-793, 2009 | 84 | 2009 |
| Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein Z Shi, YJ Liang, ZS Chen, XH Wang, Y Ding, LM Chen, LW Fu Oncology reports 17 (4), 969-976, 2007 | 77 | 2007 |
| Prostaglandin E2 signaling: alternative target for glioblastoma? J Jiang, J Qiu, Q Li, Z Shi Trends in cancer 3 (2), 75-78, 2017 | 73 | 2017 |
| Roles of sildenafil in enhancing drug sensitivity in cancer Z Shi, AK Tiwari, AS Patel, LW Fu, ZS Chen Cancer research 71 (11), 3735-3738, 2011 | 73 | 2011 |
| Sipholenol A, a marine‐derived sipholane triterpene, potently reverses P‐glycoprotein (ABCB1)‐mediated multidrug resistance in cancer cells Z Shi, S Jain, IW Kim, XX Peng, I Abraham, DTA Youssef, LW Fu, ... Cancer science 98 (9), 1373-1380, 2007 | 73 | 2007 |
| Regorafenib overcomes chemotherapeutic multidrug resistance mediated by ABCB1 transporter in colorectal cancer: in vitro and in vivo study YJ Wang, YK Zhang, GN Zhang, SB Al Rihani, MN Wei, P Gupta, ... Cancer letters 396, 145-154, 2017 | 67 | 2017 |
| Cyclin-dependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer XX Chen, FF Xie, XJ Zhu, F Lin, SS Pan, LH Gong, JG Qiu, WJ Zhang, ... Oncotarget 6 (17), 14926, 2015 | 67 | 2015 |
| The epidermal growth factor tyrosine kinase inhibitor AG1478 and erlotinib reverse ABCG2-mediated drug resistance Z Shi, S Parmar, XX Peng, T Shen, RW Robey, SE Bates, LW Fu, Y Shao, ... Oncology reports 21 (2), 483-489, 2009 | 67 | 2009 |
